pyrroles has been researched along with sl 327 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, DJ; Bitner, RS; Briggs, CA; Buccafusco, J; Bunnelle, WH; Curzon, P; Decker, MW; Frost, JM; Gopalakrishnan, M; Gronlien, JH; Gubbins, E; Li, J; Malysz, J; Markosyan, S; Marsh, K; Meyer, MD; Nikkel, AL; Radek, RJ; Robb, HM; Sullivan, JP; Timmermann, D | 1 |
| Chen, S; Wang, W; Zhao, L; Zhou, J | 1 |
2 other study(ies) available for pyrroles and sl 327
| Article | Year |
|---|---|
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Aminoacetonitrile; Animals; Central Nervous System Agents; Cognition; Cyclic AMP Response Element-Binding Protein; Extracellular Signal-Regulated MAP Kinases; Humans; Learning; Macaca mulatta; Male; Mental Processes; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Pyridazines; Pyrroles; Rats; Receptors, Nicotinic; Signal Transduction; Treatment Outcome; Xenopus | 2007 |
Combination of SL327 and Sunitinib Malate leads to an additive anti-cancer effect in doxorubicin resistant thyroid carcinoma cells.
Topics: Aminoacetonitrile; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Humans; Indoles; Mice, Nude; Pyrroles; Sunitinib; Taxoids; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2017 |